US Patent 10864194 Methods for treating heterotopic ossification
Patent 10864194 was granted and assigned to Clementia Pharmaceuticals on December, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 8, 2017
0
Date of Patent
December 15, 2020
0
Patent Applicant
Patent Application Number
16308012
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10864194 Methods for treating heterotopic ossification
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.